Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-25-000117
Filing Date
2025-02-07
Accepted
2025-02-07 13:28:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4269
  Complete submission text file 0000947871-25-000117.txt   6260
Mailing Address BAHNHOFSTRASSE 9 ZURICH V8 8001
Business Address BAHNHOFSTRASSE 9 ZURICH V8 8001 0041-044-292-2113
Zurcher Kantonalbank (Zurich Cantonalbank) (Filed by) CIK: 0001368163 (see all company filings)

EIN.: 980477436 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Subject) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93586 | Film No.: 25600733
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)